Fixed-dose combination antituberculosis therapy as a risk factor for tuberculosis recurrence: an evidence-based case report

Fixed-dose combination antituberculosis therapy as a risk factor for tuberculosis recurrence: an evidence-based case report

Background: a patient with a history of tuberculosis (TB) has a risk up to 27% to develop recurrence within 2 years after being cured. Indonesia itself has more than 7,500 recurrent cases annually, regardless of reinfection or relapse. This is an important problem, as recurrent TB is associated with...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Arvin Pramudita, Cleopas M Rumende, Ardi Findyartini
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Interna Publishing 2017-04-01
Σειρά:	Acta Medica Indonesiana
Θέματα:	tuberculosis fixed-dose combination recurrent
Διαθέσιμο Online:	http://www.actamedindones.org/index.php/ijim/article/view/327

Παρόμοια τεκμήρια

Treating more with less: Effectiveness and event outcomes of antituberculosis fixed-dose combination drug versus separate-drug formulation (Ethambutol, Isoniazid, Rifampicin and Pyrazinamide) for pulmonary tuberculosis patients in real-world clinical practice
ανά: Jacqueline Mui Lan Lai, κ.ά.
Έκδοση: (2019-01-01)

Relative Bioavailability of Rifampicin in Four Chinese Fixed-dose Combinations Compared with Rifampicin in Free Combinations
ανά: Hui Zhu, κ.ά.
Έκδοση: (2015-01-01)

Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment
ανά: Jiun-Ting Wu, κ.ά.
Έκδοση: (2015-06-01)

In vitro antimicrobial efficacy of a fixed-dose combination of RHZE against M. tuberculosis
ανά: Vanessa Albertina Agertt, κ.ά.

Potential side effects of medicine on patients with tuberculosis fixed-dose combination in dr. Pirngadi Hospital, Medan
ανά: EVA SARTIKA DASOPANG, κ.ά.
Έκδοση: (2020-02-01)

Comparison of sputum conversion time in tuberculosis treatment with fix-dose combination drugs and separate drug regimens
ανά: Soheila Khodakarim, κ.ά.
Έκδοση: (2020-01-01)

Treatment outcome in smear-positive pulmonary tuberculosis patients treated with a fixed-dose drug combination regimen in comparison with a separate regimen: a randomized clinical trial
ανά: Seyed Saeed Hashemi Nazari, κ.ά.
Έκδοση: (2021-01-01)

Experience of Fixed-Dose Combinations of Anti-Tuberculosis Drugs for Preventive Treatment in Children
ανά: O. D. Baronova, κ.ά.
Έκδοση: (2023-12-01)

Optimization of Hypertension Treatment using Fixed-Dose Combination of Perindropril/Amlodipine
ανά: Evan Hindoro, κ.ά.
Έκδοση: (2015-12-01)

Fixed dosed combinations in the treatment of hypertension
ανά: Gabriel Hancu, κ.ά.
Έκδοση: (2020-03-01)

Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects
ανά: A. L. Khokhlov, κ.ά.
Έκδοση: (2022-05-01)

Assessment of treatment outcomes of daily fixed-dose combination therapy among drug-sensitive pulmonary tuberculosis patients: A prospective study from Bengaluru, India
ανά: M Sumana, κ.ά.
Έκδοση: (2024-07-01)

From combined therapy to fixed-dose combinations
ανά: I. P. Kolos, κ.ά.
Έκδοση: (2008-08-01)

A promising choice in hypertension treatment: Fixed-dose combinations
ανά: Xinhuan Wan, κ.ά.
Έκδοση: (2014-02-01)

Fixed-dose versus separate drug combinations for antihypertensive treatment: literature review
ανά: José Luis Calleja Rivero
Έκδοση: (2016-09-01)

Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar
ανά: Mohammad H. Al-Shaer, κ.ά.
Έκδοση: (2018-08-01)

Therapy compliance and fixed-dose combinations in arterial hypertension treatment. Focus on a fixed-dose combination of felodipine and metoprolol
ανά: S. A. Shalnova, κ.ά.
Έκδοση: (2009-12-01)

The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TB
ανά: Lena Faust, κ.ά.
Έκδοση: (2019-08-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
ανά: A. O. Konradi, κ.ά.
Έκδοση: (2020-04-01)

Critical Analysis of Cardiovascular and Central Nervous System Fixed Dose Combinations Available in Indian Market
ανά: Krunal Prajapati, κ.ά.
Έκδοση: (2016-12-01)

Fixed-dose combinations in the treatment of hypertension to increase adherence
ανά: T. E. Morozova, κ.ά.
Έκδοση: (2020-12-01)

A cost-minimization analysis of combination therapy in hypertension: fixed-dose vs extemporary combinations
ανά: Marco Bellone, κ.ά.
Έκδοση: (2013-12-01)

Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men
ανά: Choi HK, κ.ά.
Έκδοση: (2016-10-01)

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
ανά: Hayes J, κ.ά.
Έκδοση: (2016-07-01)

Enhanced Stability and Compatibility of Montelukast and Levocetirizine in a Fixed-Dose Combination Monolayer Tablet
ανά: Tae Han Yun, κ.ά.
Έκδοση: (2024-07-01)

The use of capillary electrophoresis in the simultaneous determination of fixed-dose combination drugs for cardiovascular diseases
ανά: Gabriel Hancu, κ.ά.
Έκδοση: (2020-09-01)

Regulatory requirements for marketing fixed dose combinations
ανά: B G Jayasheel
Έκδοση: (2010-01-01)

Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution
ανά: A. O. Konradi, κ.ά.
Έκδοση: (2025-02-01)

Clinical Benefit of Fixed‐Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia
ανά: Chia‐Pin Lin, κ.ά.
Έκδοση: (2024-05-01)

The Adherence to Fixed-Dose Combination Antiretroviral Therapy and Viral Load in HIV Patients
ανά: Salma Auliannissa, κ.ά.
Έκδοση: (2020-01-01)

LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review
ανά: Rogliani P, κ.ά.
Έκδοση: (2018-10-01)

From Scylla to Charybdis: Fixed drug combinations for tuberculosis and increased ethambutol-induced optic neuropathy in India
ανά: Archana Bhargava, κ.ά.
Έκδοση: (2022-01-01)

Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers
ανά: Oh M, κ.ά.
Έκδοση: (2017-12-01)

IMPACT OF THE FORM OF MEDICATION ON TREATMENT ADHERENCE IN RESPIRATORY TUBERCULOSIS PATIENTS
ανά: T. E. Tyulkova, κ.ά.
Έκδοση: (2018-01-01)

Triple fixed-dose combination in the treatment of hypertension: the results of the Russian observational study TRICOLOR
ανά: Yu. A. Karpov, κ.ά.
Έκδοση: (2020-11-01)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects
ανά: Oh M, κ.ά.
Έκδοση: (2019-04-01)

Desenvolvimento e validação de método analítico para determinação simultânea de lamivudina, zidovudina e nevirapina em comprimidos dose-fixa combinada por cromatografia líquida de alta eficiência Development and validation of an analytical method for simultaneous determination of fixed-dose combination tablets of lamivudine, zidovudine and nevirapine by hight performance liquid chromatography
ανά: Zênia Maria Maciel Lavra, κ.ά.
Έκδοση: (2008-01-01)

Socio-Demographic Profile, Treatment Outcome & Factors Influencing Outcome among Tuberculosis Cases Treated On Daily Regimen: A Cross-Sectional Study at District Tuberculosis Centre, Uttarakannada
ανά: Girish HO, κ.ά.
Έκδοση: (2019-12-01)

Glyceroniosomes for enhanced intestinal absorption of hydrochlorothiazide and lisinopril in their fixed dose combination
ανά: Aya R. Elbasuony, κ.ά.
Έκδοση: (2024-10-01)

Pharmacokinetics of a Fixed-Dose Combination Product of Dapagliflozin and Linagliptin and Its Comparison with Co-Administration of Individual Tablets in Healthy Humans
ανά: Jin-Woo Park, κ.ά.
Έκδοση: (2022-03-01)